2025 / 03

DOI: 10.24075/brsmu.2025.033
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Intravital microscopy for assessment of anti-tumor nanotherapeutic delivery

Ivanova EV1, Naumenko VA2, Garanina AS1, Abakumov MA3
About authors

1 National University of Science and Technology MISIS, Moscow, Russia

2 Serbsky National Medical Research Centre for Psychiatry and Narcology, Moscow, Russia

3 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Elizaveta V. Ivanova
Leninsky Prospect, 4, str. 1, 119049, Moscow, Russia; ur.sisim.ude@4103081m

About paper

Funding: the study was supported by the Russian Science Foundation grant (project No. 21-74-20077).

Author contribution: Ivanova EV, Naumenko VA — manuscript writing, design of the figures; Garanina AS, Abakumov MA — manuscript editing.

Received: 2025-06-17 Accepted: 2025-06-29 Published online: 2025-06-30
|
  1. Ahlawat J, et al. Nanoparticles in Biomedical Applications. In: Green Nanoparticles. Springer, Cham, 2020; p. 227–250.
  2. Nakamura Y, et al. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? Bioconjug Chem. 2016; 27 (10): 2225–38.
  3. Bertrand N, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014; 66: 2–25.
  4. Wilhelm S, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016; 1 (5): 16014.
  5. Danhier F. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016; 244 (Pt A): 108–21.
  6. Mitchell MJ, King MR. Leukocytes as carriers for targeted cancer drug delivery. Expert Opin Drug Deliv. 2015; 12 (3): 375–92.
  7. Tiet P, Berlin JM. Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapy. Biochem Pharmacol. 2017; 145: 18–26.
  8. Xue J, et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol. 2017; 12 (7): 692–700.
  9. Chu D, et al. Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration. Adv Mater. 2017; 29 (27): 1701021.
  10. Chu D, et al. Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy. Adv Healthc Mater. 2016; 5 (9): 1088–93.
  11. Luo X, et al. Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)–octadecylamine conjugate for lung cancer treatment. Drug Deliv. 2018; 25 (1): 1200–12.
  12. Smith BR, et al. High-resolution, serial intravital microscopic imaging of nanoparticle delivery and targeting in a small animal tumor model. Nano Today. 2013; 8 (2): 126–37.
  13. Smith BR. et al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol. 2014; 9 (6): 481–7.
  14. Qiang L, et al. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotechnology. BioMed Central. 2019; 17 (1): 83.
  15. Chen K, et al. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma. Theranostics. 2019; 9 (10): 2984–98.
  16. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011; 144 (5): 646–74.
  17. Schießl IM, Castrop H. Deep insights: intravital imaging with two-photon microscopy // Pflugers Archiv European Journal of Physiology. Springer Verlag. 2016; 468 (9): 1505–16.
  18. Naumenko V, Jenne C, Mahoney DJ. Intravital microscopy for imaging the tumor microenvironment in live mice. Methods Mol Biol. 2016; 1458: 217–30.
  19. Li JL, et al. Intravital multiphoton imaging of immune responses in the mouse ear skin. Nat Protoc. 2012; 7 (2): 221–34.
  20. Ritsma L, et al. Surgical implantation of an abdominal imaging window for intravital microscopy. Nat Protoc. 2013; 8 (3): 583–94.
  21. Stolp B, Melican K. Microbial pathogenesis revealed by intravital microscopy: pros, cons and cautions. FEBS Lett. 2016; 590 (13): 2014–26.
  22. Miller MA, Weissleder R. Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev. 2017; 113: 61–86.
  23. Inturi S, et al. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. ACS Nano. 2015; 9 (11): 10758–68.
  24. Arami H, et al. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev. 2015; 44 (23): 8576–607.
  25. Miller MA, et al. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015; 6: 8692.
  26. Naumenko V, et al. Neutrophils in viral infection. Cell Tissue Res. 2018; 371 (3): 505–16.
  27. Naumenko V, et al. Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors. Acta Biomater. 2020; 104: 176–87.
  28. Naumenko VA, et al. Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors. ACS Nano. 2019; 13 (11).
  29. Moghimi SM, Simberg D. Nanoparticle transport pathways into tumors. J Nanoparticle Res. 2018; 20 (6): 169.
  30. Park SA, Hyun Y-M. Neutrophil Extravasation Cascade: What Can We Learn from Two-photon Intravital Imaging? Immune Netw. 2016; 16 (6): 317–21.
  31. Naumenko V, et al. Intravital microscopy reveals a novel mechanism of nanoparticles excretion in kidney. J Control Release. 2019; 307: 368–78.
  32. Yang K, et al. Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy. Nano Lett. 2010; 10 (9): 3318–23.
  33. Yang K, et al. In Vivo Pharmacokinetics, Long-Term Biodistribution, and Toxicology of PEGylated Graphene in Mice. ACS Nano. 2011; 5 (1): 516–22.
  34. Gary-Bobo M, et al. Mannose-Functionalized Mesoporous Silica Nanoparticles for Efficient Two-Photon Photodynamic Therapy of Solid Tumors. Angew Chemie Int Ed. 2011; 50 (48): 11425–9.
  35. Lu J. et al. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small. NIH Public Access. 2010; 6 (16): 1794–805.
  36. Fischer NO, et al. Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform. PLoS One. 2014; 9 (3): e93342.
  37. He Q, et al. In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation. Small. 2011; 7 (2): 271–80.
  38. He X, et al. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem. 2008; 80 (24): 9597–603.
  39. Fu C, et al. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013; 34 (10): 2565–75.
  40. Gómez-Vallejo V, et al. PEG-copolymer-coated iron oxide nanoparticles that avoid the reticuloendothelial system and act as kidney MRI contrast agents. Nanoscale. 2018; 10 (29): 14153–64.
  41. Ruggiero A, et al. Paradoxical glomerular filtration of carbon nanotubes. Proc Natl Acad Sci U. S. A. 2010; 107 (27): 12369–74.
  42. Jasim DA, et al. Tissue distribution and urinary excretion of intravenously administered chemically functionalized graphene oxide sheets. Chem Sci. 2015; 6 (7): 3952–64.
  43. Jasim DA, et al. The Effects of Extensive Glomerular Filtration of Thin Graphene Oxide Sheets on Kidney Physiology. ACS Nano. 2016; 10 (12): 10753–67.
  44. Huang X, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011; 5 (7): 5390–9.
  45. Nair AV, et al. Characterizing the interactions of organic nanoparticles with renal epithelial cells in vivo. ACS Nano. 2015; 9 (4): 3641–53.
  46. Naumenko VA, et al. Intravital imaging of liposome behavior upon repeated administration: A step towards the development of liposomal companion diagnostic for cancer nanotherapy. J Control Release. 2021; 330: 244–56.
  47. Fisher DT, et al. Intraoperative intravital microscopy permits the study of human tumour vessels. Nat Commun Nature Publishing Group. 2016; 7 (1): 1–9.